NCT03727633 2026-01-05
LIDA-BII
University Hospital, Montpellier
Phase 2 Recruiting
Clinical Trials
6 trialsNCT06492408 2024-07-09
Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.
Second Affiliated Hospital of Guangzhou Medical University
Phase 2 Recruiting
NCT06482801 2024-07-01
Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT
Second Affiliated Hospital of Guangzhou Medical University
Phase 2 Recruiting
NCT05280444 2022-12-29
Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma
Zhongda Hospital
Phase 2/3 Unknown
NCT05053386 2021-09-22
Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma
Zhejiang Cancer Hospital
Phase NA Unknown
NCT01040559 2013-01-09
Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas
Centre Hospitalier Universitaire Dijon
Phase 1 Completed